Charles Schwab’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Charles Schwab’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-45,129	Closed	-$1.1M	–	3090
2017 Q4	$1.1M	Buy	45,129 +5,416	+14%	+$104K	﹤0.01%	2480
2017 Q3	$734K	Buy	39,713 +1,914	+5%	+$33.2K	﹤0.01%	2601
2017 Q2	$626K	Buy	37,799 +9,469	+33%	+$132K	﹤0.01%	2622
2017 Q1	$391K	Buy	28,330 +9,855	+53%	+$158K	﹤0.01%	2731
2016 Q4	$351K	Buy	18,475 +770	+4%	+$14.8K	﹤0.01%	2785
2016 Q3	$393K	Buy	17,705 +680	+4%	+$12.8K	﹤0.01%	2704
2016 Q2	$312K	Buy	17,025 +210	+1%	+$3.62K	﹤0.01%	2771
2016 Q1	$306K	Buy	16,815 +255	+2%	+$4.13K	﹤0.01%	2766
2015 Q4	$280K	Buy	16,560 +325	+2%	+$5.52K	﹤0.01%	2885
2015 Q3	$293K	Buy	16,235 +945	+6%	+$21K	﹤0.01%	2837
2015 Q2	$396K	Buy	+15,290	New	+$387K	﹤0.01%	2768

Charles Schwab's ENTL Position: Q1 2018 in Review

Charles Schwab sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 45,129 shares — an estimated $1.1M sold.

Charles Schwab first reported a position in ENTL in Q2 2015 and held it in 11 quarters. The position peaked at $1.1M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Charles Schwab reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Charles Schwab sold 45,129 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.1M.
Charles Schwab first reported a position in Entellus Medical, Inc. Common Stock in Q2 2015 and held it in 11 quarters.
Charles Schwab's Entellus Medical, Inc. Common Stock position peaked at $1.1M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Charles Schwab's 13F filing for Q1 2018, filed 7 May 2018.